The documentation needed to support any brand name candidate will undergo intense scrutiny by regulatory agencies. It must be written with a level of expertise appropriate for regulatory peer review.
Our brand name submission documents adhere to the latest guidance issued by the FDA, EMA and Health Canada. Customized to your brand, they are written with the scientific precision expected for such an evaluation. A crucial step in pharmaceutical naming success, the Addison Whitney submission documentation development process is revered by the industry and is synonymous with approval.
« BACK TO RESEARCH & ANALYSIS